Seraxis
Germantown, United States · Founded 2013 · $47.0M raised
- Headquarters
- Germantown, Maryland
- Founded
- 2013
- Business Model
- B2B
- Website
- seraxis.com
- Total Funding
- $47.0M
- Last Round
- $40.0M Series CJul 2025
- Rounds
- 4
About
Biotech developing cell replacement therapy for insulin-dependent diabetes using lab-grown pancreatic islet cells.
Summary
Seraxis is a Biotech company based in Germantown, United States, founded in 2013. It has raised $47.0M in total across 4 rounds, most recently a $40.0M Series C round in Jul 2025. Investors include Polaris Partners, Eli Lilly and Frazier Healthcare.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...